Byrne, Jonah F. http://orcid.org/0000-0002-7046-0630
Healy, Colm
Mongan, David http://orcid.org/0000-0001-7931-9636
Susai, Subash Raj
Zammit, Stan
Fӧcking, Melanie http://orcid.org/0000-0002-6299-2952
Cannon, Mary
Cotter, David R. http://orcid.org/0000-0003-4308-0648
Funding for this research was provided by:
Wellcome Trust (220438Z/20/Z, 203930/B/16/Z, 220438Z/20/Z)
Science Foundation Ireland (16/RC/3948, 16/RC/3948, 16/RC/3948)
Health Research Board (ILP-PHR-2019-009, 203930/B/16/Z, ILP-POR-2017-039)
University of Bristol
Wellcome Trust (220438Z/20/Z)
M.C. is supported by a European Research Council Consolidator Award
Article History
Received: 4 April 2022
Revised: 22 August 2022
Accepted: 25 August 2022
First Online: 9 September 2022
Competing interests
: DM, MC and DRC report a patent pending (UK Patent Application No. 1919155.0, “Biomarkers to predict psychosis”). CH, MF, SRS, SZ and JFB report no financial relationships with commercial interests.
: Approval for ALSPAC was obtained from ALSPAC Ethics and Law Committee and local research ethics committees. Consent for biological samples was collected in accordance with the Human Tissue Act (2004). Written informed consent for the use of questionnaire and clinic data was obtained from all subjects following recommendations of the ALSPAC Ethics and Law Committee at the time. Ethical approval for the analysis of inflammatory biomarker levels was granted by the Royal College of Surgeons in Ireland (REC1240bb). The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.